Monitor for any shifts in board dynamics or strategic direction ahead of the 2026 Annual Meeting, but no trading catalyst expected from this routine governance update.
COLL drugs
COLL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 8 $33.43entry
- T+1 · 7mo ago +5.44%α +4.87% · $35.25
- T+5 · 7mo ago +4.49%α +0.97% · $34.93
- T+20 · 7mo ago +5.65%α −2.89% · $35.32
- T+60 · 4mo ago +10.77%α +0.31% · $37.03
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Collegium Pharmaceutical announced the nomination of Michael Donovan to its board of directors and the retirement of director John Fallon at the 2026 Annual Meeting. Fallon's departure is part of board refreshment and not due to disagreement.
Key Facts
- Michael Donovan, former EY audit partner with life sciences expertise, nominated to board
- Dr. John Fallon to retire from board after serving since 2016
- No CEO/CFO departure or executive change involved
- Board refreshment cited as reason for transition
Financial Impact
No immediate financial impact disclosed
Risk Factors
- Potential loss of medical expertise with Dr. Fallon's departure
- Board transition risk if new member lacks industry-specific experience
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-024061 |
| Document: 0001628280-26-024061-index-headers.html | 0001628280-26-024061 |
| Document: 0001628280-26-024061-index.html | 0001628280-26-024061 |
| Document: 0001628280-26-024061.txt | 0001628280-26-024061 |
Track record
24 reports on COLL
1 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +0.28% at T+1 after the Aug 13, 2026 report. 1 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $25.68 Now $25.43 −0.97% settles Nov 17
- Nov 10, 20266d ago SC 13G/A Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $24.47 to $24.81 Now $25.43 +3.92% ▲ +1.39% +0.07% vs SPY
- Nov 9, 20267d ago Institutional Cluster Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Neutral 5/10 Entry $25.16 to $24.21 Now $25.43 +1.07% ▼ −3.78% −4.09% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $23.80 to $23.68 Now $25.43 +6.85% ▼ −0.50% −0.03% vs SPY
- Oct 29, 202618d ago SC 13G/A Neutral 3/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
- Oct 29, 202618d ago Press Release Neutral 2/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $23.50 to $22.96 Now $25.43 +8.21% ▼ −2.30% −1.78% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers